10 live listings from $29.99 – $69.99 · 20% off with code PEPTIDEGRADING
Discounted only
GHK-Cu
If you've ever seen a blue-tinted skincare serum, you've already met GHK-Cu. It's a copper-carrying tripeptide that was first pulled out of human blood plasma back in 1973, and it's been sitting in cosmetics for decades. What's newer is its life as a research peptide: vials of it, and blends like Glow and Klow that put it alongside BPC-157 and TB-500 . I'll say upfront that GHK-Cu is a bit unusual in this catalog. It has a long research history, and the skin-care version is a mainstream cosmetic ingredient. But no GHK-Cu drug is approved by the FDA, and the injectable side is much less studied than the creams. On Peptide Grading , we line up the research-labeled listings, with vendors, sizes, price per mg, and COAs , so you can see the differences. A listing isn't a recommendation to use it.
Retatrutide is an experimental once-weekly injection from Eli Lilly (internal code LY3437943). It's a single molecule that activates three receptors: GIP, GLP-1, and glucagon. Tirzepatide covers the first two, and retatrutide adds the third. It isn't approved anywhere, for anything. Lilly has said it plans to file with the FDA in the first quarter of 2027. On Peptide Grading , we list the research-labeled vials with sizes, price per mg, and COAs side by side. Being listed there isn't an endorsement, and those vials aren't Lilly's product.
BPC-157 is a 15-amino-acid peptide first described from gastric juice. Most of the published work is preclinical, with studies covering tendon, muscle, gastrointestinal, vascular, and other injury models. Researchers have looked at several signaling pathways, including VEGFR2, nitric oxide, Akt-eNOS, and ERK1/2 . Other work has focused on angiogenesis, fibroblast activity, endothelial responses, and inflammation. Human data are still sparse. Small studies have looked at knee pain, interstitial cystitis, and intravenous safety and pharmacokinetics , but the number of human studies remains small and larger controlled trials are not available.
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded by a short open reading frame in the mitochondrial 12S rRNA region. Peptide Grading tracks MOTS-c vendors, quantities, prices, shipping details, and COA information to make research-product listings easier to compare.
NAD+ (nicotinamide adenine dinucleotide) is a naturally occurring cellular coenzyme involved in energy metabolism, redox reactions, and several signaling pathways. It is found throughout living cells and continuously shifts between its oxidized NAD+ and reduced NADH forms. Unlike peptide compounds, NAD+ is a dinucleotide, making its research profile quite different from synthetic peptide products.
Semax is a synthetic seven-amino-acid peptide derived from ACTH(4–7) with an added Pro-Gly-Pro sequence. Research has mainly examined its effects on neurotrophic signaling, cerebral ischemia, and cellular responses in the nervous system. The evidence includes experimental studies and some clinical research, but its clinical and regulatory status varies by jurisdiction.
TB-500 is a synthetic peptide commonly identified as the N-terminal acetylated LKKTETQ fragment of thymosin beta-4. Research has focused on its molecular relationship to actin, cell migration, angiogenesis, and other cellular response pathways. Peptide Grading check TB-500 listings, pricing, vendor information, and COA details
Tesamorelin is a synthetic 44-amino-acid analogue of human growth hormone-releasing factor (GRF). The peptide carries an N-terminal hexenoyl group, a structural change that distinguishes it from native GRF while retaining activity at the GRF receptor. Tesamorelin has been studied extensively in human endocrine research, particularly in work involving growth hormone release and IGF-1 response. Peptide Grading compares current listings by supplier, quantity, stated specifications, COA availability, shipping, and price per mg.
Selank comes from tuftsin, a peptide that occurs naturally in the body. It is made up of seven amino acids, which puts it in the heptapeptide group. There has been research on Selank for a number of years. Most of it has been done in experimental models. A smaller number of studies have involved people. Researchers have looked at several things along the way, including GABA, enkephalin activity, stress responses, and neurotrophic factors . However, these findings do not change Selank's current regulatory status.
If you've ever seen a blue-tinted skincare serum, you've already met GHK-Cu. It's a copper-carrying tripeptide that was first pulled out of human blood plasma back in 1973, and it's been sitting in cosmetics for decades. What's newer is its life as a research peptide: vials of it, and blends like Glow and Klow that put it alongside BPC-157 and TB-500 . I'll say upfront that GHK-Cu is a bit unusual in this catalog. It has a long research history, and the skin-care version is a mainstream cosmetic ingredient. But no GHK-Cu drug is approved by the FDA, and the injectable side is much less studied than the creams. On Peptide Grading , we line up the research-labeled listings, with vendors, sizes, price per mg, and COAs , so you can see the differences. A listing isn't a recommendation to use it.
Retatrutide is an experimental once-weekly injection from Eli Lilly (internal code LY3437943). It's a single molecule that activates three receptors: GIP, GLP-1, and glucagon. Tirzepatide covers the first two, and retatrutide adds the third. It isn't approved anywhere, for anything. Lilly has said it plans to file with the FDA in the first quarter of 2027. On Peptide Grading , we list the research-labeled vials with sizes, price per mg, and COAs side by side. Being listed there isn't an endorsement, and those vials aren't Lilly's product.
BPC-157 is a 15-amino-acid peptide first described from gastric juice. Most of the published work is preclinical, with studies covering tendon, muscle, gastrointestinal, vascular, and other injury models. Researchers have looked at several signaling pathways, including VEGFR2, nitric oxide, Akt-eNOS, and ERK1/2 . Other work has focused on angiogenesis, fibroblast activity, endothelial responses, and inflammation. Human data are still sparse. Small studies have looked at knee pain, interstitial cystitis, and intravenous safety and pharmacokinetics , but the number of human studies remains small and larger controlled trials are not available.
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded by a short open reading frame in the mitochondrial 12S rRNA region. Peptide Grading tracks MOTS-c vendors, quantities, prices, shipping details, and COA information to make research-product listings easier to compare.
NAD+ (nicotinamide adenine dinucleotide) is a naturally occurring cellular coenzyme involved in energy metabolism, redox reactions, and several signaling pathways. It is found throughout living cells and continuously shifts between its oxidized NAD+ and reduced NADH forms. Unlike peptide compounds, NAD+ is a dinucleotide, making its research profile quite different from synthetic peptide products.
Semax is a synthetic seven-amino-acid peptide derived from ACTH(4–7) with an added Pro-Gly-Pro sequence. Research has mainly examined its effects on neurotrophic signaling, cerebral ischemia, and cellular responses in the nervous system. The evidence includes experimental studies and some clinical research, but its clinical and regulatory status varies by jurisdiction.
TB-500 is a synthetic peptide commonly identified as the N-terminal acetylated LKKTETQ fragment of thymosin beta-4. Research has focused on its molecular relationship to actin, cell migration, angiogenesis, and other cellular response pathways. Peptide Grading check TB-500 listings, pricing, vendor information, and COA details
Tesamorelin is a synthetic 44-amino-acid analogue of human growth hormone-releasing factor (GRF). The peptide carries an N-terminal hexenoyl group, a structural change that distinguishes it from native GRF while retaining activity at the GRF receptor. Tesamorelin has been studied extensively in human endocrine research, particularly in work involving growth hormone release and IGF-1 response. Peptide Grading compares current listings by supplier, quantity, stated specifications, COA availability, shipping, and price per mg.
Selank comes from tuftsin, a peptide that occurs naturally in the body. It is made up of seven amino acids, which puts it in the heptapeptide group. There has been research on Selank for a number of years. Most of it has been done in experimental models. A smaller number of studies have involved people. Researchers have looked at several things along the way, including GABA, enkephalin activity, stress responses, and neurotrophic factors . However, these findings do not change Selank's current regulatory status.